Peter Lechleitner

4.7k total citations
53 papers, 1.7k citations indexed

About

Peter Lechleitner is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Internal Medicine. According to data from OpenAlex, Peter Lechleitner has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Internal Medicine. Recurrent topics in Peter Lechleitner's work include Acute Myocardial Infarction Research (14 papers), Cardiac Imaging and Diagnostics (8 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Peter Lechleitner is often cited by papers focused on Acute Myocardial Infarction Research (14 papers), Cardiac Imaging and Diagnostics (8 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Peter Lechleitner collaborates with scholars based in Austria, Germany and France. Peter Lechleitner's co-authors include F Dienstl, Bernd Puschendorf, Ina Wagner, Johannes Mair, N Genser, Erika Artner‐Dworzak, Johannes Mair, Andreas Schüler, Angelika Reißig and Gebhard Mathis and has published in prestigious journals such as Stroke, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Peter Lechleitner

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Lechleitner Austria 21 994 556 263 235 213 53 1.7k
Karin Wildi Switzerland 19 1.2k 1.2× 677 1.2× 358 1.4× 82 0.3× 108 0.5× 81 1.7k
Jesse E. Adams United States 14 1.6k 1.6× 725 1.3× 627 2.4× 54 0.2× 260 1.2× 23 2.2k
Simon Chakko United States 27 1.7k 1.7× 352 0.6× 533 2.0× 202 0.9× 110 0.5× 66 2.3k
S. Hagl Germany 20 856 0.9× 150 0.3× 607 2.3× 107 0.5× 112 0.5× 117 1.5k
F S Apple United States 9 1.0k 1.0× 488 0.9× 298 1.1× 24 0.1× 152 0.7× 15 1.5k
Daniel J. Ullyot United States 25 1.4k 1.4× 431 0.8× 1.1k 4.2× 118 0.5× 163 0.8× 56 2.2k
Rune Wiseth Norway 28 1.2k 1.2× 594 1.1× 735 2.8× 46 0.2× 104 0.5× 102 2.1k
F Dienstl Austria 17 939 0.9× 414 0.7× 230 0.9× 24 0.1× 179 0.8× 77 1.5k
J. C. Greenfield United States 23 1.5k 1.5× 944 1.7× 569 2.2× 36 0.2× 184 0.9× 62 2.3k

Countries citing papers authored by Peter Lechleitner

Since Specialization
Citations

This map shows the geographic impact of Peter Lechleitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lechleitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lechleitner more than expected).

Fields of papers citing papers by Peter Lechleitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lechleitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lechleitner. The network helps show where Peter Lechleitner may publish in the future.

Co-authorship network of co-authors of Peter Lechleitner

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lechleitner. A scholar is included among the top collaborators of Peter Lechleitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lechleitner. Peter Lechleitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frass, Michael, et al.. (2024). Use of Homeopathy in Patients Suffering from Long COVID-19 (LONGCOVIHOM): A Case Series. OBM Integrative and Complementary Medicine. 9(3). 1–21.
2.
3.
Frass, Michael, et al.. (2021). Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series. Complementary Therapies in Clinical Practice. 44. 101415–101415. 10 indexed citations
4.
Lechleitner, Peter, et al.. (2019). Machbarkeit und Auswirkungen von Badeanwendungen mit einer verdünnten fossilen Sole auf Blutdruck, Gefäßregulation und autonome Funktion. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. 29(1). 58–63.
5.
Lechleitner, Peter, et al.. (2019). Effects of a one-week vacation with various activity programs on cardiovascular parameters. The Journal of Sports Medicine and Physical Fitness. 59(2). 335–339. 6 indexed citations
6.
Eigentler, Andrea, Peter Lechleitner, Christian J. Wiedermann, et al.. (2008). Therapierefraktäre fulminante Meningokokkensepsis. DMW - Deutsche Medizinische Wochenschrift. 116(20). 772–774.
7.
Mathis, Gebhard, Wolfgang Blank, Angelika Reißig, et al.. (2005). Thoracic Ultrasound for Diagnosing Pulmonary Embolism. CHEST Journal. 128(3). 1531–1538. 185 indexed citations
8.
Madl, Christian, Walter Hasibeder, Peter Lechleitner, et al.. (2002). [Recommendations for prognostic assessment of cerebral hypoxia after cardiopulmonary resuscitation--Austrian Interdisciplinary Consensus Conference].. PubMed. 114(10-11). 422–7. 3 indexed citations
9.
10.
Berek, Klaus, Adolf Schinnerl, Christian Traweger, et al.. (1997). The prognostic significance of coma-rating, duration of anoxia and cardiopulmonary resuscitation in out-of-hospital cardiac arrest. Journal of Neurology. 244(9). 556–561. 19 indexed citations
11.
Hirschl, Michael M., Peter Lechleitner, Guy Friedrich, et al.. (1996). Usefulness of a new rapid bedside troponin T assay in patients with chest pain. Resuscitation. 32(3). 193–198. 12 indexed citations
12.
Lechleitner, Peter, et al.. (1994). Bone mineral densitometry in dialyzed patients: Quantitative computed tomography versus dual photon absorptiometry. Bone. 15(4). 387–391. 32 indexed citations
13.
Mair, Johannes, Ina Wagner, Peter Lechleitner, et al.. (1993). Release of cardiac troponin T in patients with acute myocardial infarction is related to scintigraphic estimates myocardial scar. Clinical Chemistry. 39(6). 1133. 1 indexed citations
14.
Wagner, Ina, Johannes Mair, L. Fridrich, et al.. (1993). Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Coronary Artery Disease. 4(6). 537–544. 48 indexed citations
15.
Mair, Johannes, Erika Artner‐Dworzak, Peter Lechleitner, et al.. (1992). Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Heart. 68(11). 462–468. 105 indexed citations
16.
Mair, Johannes, et al.. (1991). Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. The American Journal of Cardiology. 68(17). 1545–1550. 87 indexed citations
17.
Lechleitner, Peter, N Genser, F Dienstl, & G. Mitterschiffthaler. (1991). Propofol for direct current cardioversion in cardiac risk patients. European Heart Journal. 5 indexed citations
18.
Tilg, Herbert, Johannes Mair, Manfred Herold, et al.. (1990). Acute phase response after myocardial infarction: Correlation between serum levels of cytokines and C-reactive protein. Journal of Molecular Medicine. 68(21). 1083–1083. 11 indexed citations
19.
Lechleitner, Peter, Alexander Dzien, Christian Häring, & Hartmut Glossmann. (1990). Uneventful self poisoning with a very high dose of captopril. Toxicology. 64(3). 325–329. 2 indexed citations
20.
Wencker, Marion, et al.. (1989). Rapid decrease in cyclic 3′5′-guanosine monophosphate in the earliest phase of acute myocardial infarction. The American Journal of Medicine. 86(5). 627–628. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Wildi Breakdown of academic impact, for papers by Jesse E. Adams Breakdown of academic impact, for papers by Simon Chakko Breakdown of academic impact, for papers by S. Hagl Breakdown of academic impact, for papers by F S Apple Breakdown of academic impact, for papers by Daniel J. Ullyot Breakdown of academic impact, for papers by Rune Wiseth Breakdown of academic impact, for papers by F Dienstl Breakdown of academic impact, for papers by J. C. Greenfield
Rankless by CCL
2026